BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced

Reuters12-11

Dec 10 (Reuters) - SIGA Technologies Inc SIGA.O:

INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN TREATMENT OF MPOX ANNOUNCED
SIGA TECHNOLOGIES INC - STUDY STOPPED ENROLLING PATIENTS IN ALL STUDY ARMS
SIGA TECHNOLOGIES INC - EFFICACY IN SEVERE MPOX PATIENTS NOT ASSESSED IN STUDY

Source text: nGNX9ZNHlH

Further company coverage: SIGA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490274670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-11 06:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490274670","market":"us","top_or_hot":-1,"title":"BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced</title></head><body><p><span>Dec 10 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SIGA\">SIGA Technologies Inc</a> <span>SIGA.O</span>:</p><ul><li><p>INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN TREATMENT OF MPOX ANNOUNCED</p></li><li><p>SIGA TECHNOLOGIES INC - STUDY STOPPED ENROLLING PATIENTS IN ALL STUDY ARMS</p></li><li><p>SIGA TECHNOLOGIES INC - EFFICACY IN SEVERE MPOX PATIENTS NOT ASSESSED IN STUDY</p></li></ul><p>Source text: <span>nGNX9ZNHlH</span></p><p>Further company coverage: <span>SIGA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-11 06:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA3MPV4B:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox AnnouncedDec 10 (Reuters) - SIGA Technologies Inc SIGA.O:INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA3MPV4B:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA3MPV4B:1","article_id":"2490274670","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490274670","pubTimestamp":1733869853,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox AnnouncedDec 10  - SIGA Technologies Inc SIGA.O:INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN TREATMENT OF MPOX ANNOUNCEDSIGA TECHNOLOGIES INC - STUDY STOPPED ENROLLING PATIENTS IN ALL STUDY ARMSSIGA TECHNOLOGIES INC - EFFICACY IN SEVERE MPOX PATIENTS NOT ASSESSED IN STUDYSource text: nGNX9ZNHlHFurther company coverage: SIGA.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","SIGA":"SIGA Technologies Inc","BK4007":"制药"},"translate_title":"Siga的Tecovirimat治疗Mpox的Stomp研究简要中期结果公布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":0.9},"content_text":"BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox AnnouncedDec 10 (Reuters) - SIGA Technologies Inc SIGA.O:INTERIM RESULTS FROM STOMP STUDY OF SIGA’S TECOVIRIMAT IN TREATMENT OF MPOX ANNOUNCEDSIGA TECHNOLOGIES INC - STUDY STOPPED ENROLLING PATIENTS IN ALL STUDY ARMSSIGA TECHNOLOGIES INC - EFFICACY IN SEVERE MPOX PATIENTS NOT ASSESSED IN STUDYSource text: nGNX9ZNHlHFurther company coverage: SIGA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490274670"}